LENZ Therapeutics (LENZ) Accumulated Depreciation (2020 - 2023)

LENZ Therapeutics (LENZ) has 4 years of Accumulated Depreciation data on file, last reported at $838000.0 in Q3 2023.

• Quarterly Accumulated Depreciation fell 66.81% year-over-year to $838000.0 in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $838000.0 (down 66.81% YoY) and the FY2022 annual result came in at $3.2 million, up 275.09% from the prior year.
• Accumulated Depreciation eased to $838000.0 in Q3 2023 per LENZ's latest filing, from $3.3 million in the prior quarter.
• Across five years, Accumulated Depreciation topped out at $3.9 million in Q1 2023 and bottomed at $121000.0 in Q4 2020.
• The 4-year median for Accumulated Depreciation is $1.3 million (2022), against an average of $1.7 million.
• The widest annual swing landed in 2021, when Accumulated Depreciation surged 606.61%; it then slumped 66.81% in 2023.
• Tracing LENZ's Accumulated Depreciation over 4 years: stood at $121000.0 in 2020, then surged by 606.61% to $855000.0 in 2021, then surged by 275.09% to $3.2 million in 2022, then sank by 73.87% to $838000.0 in 2023.
• Per Business Quant, the three latest LENZ Accumulated Depreciation figures stand at $838000.0 (Q3 2023), $3.3 million (Q2 2023), and $3.9 million (Q1 2023).

Peer Comparison